Skip to search formSkip to main contentSkip to account menu

MultiStem

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract 71: Final Results of the B01-02 Phase 2 Trial Testing the Safety and Efficacy of MultiStem® in Treatment of Ischemic Stroke
Introduction: MultiStem is an adult, adherent, stem cell product, having shown safety and efficacy in other clinical… 
2016
2016
Clinical‐Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes
MultiStem cells are clinical‐grade multipotent adult bone marrow‐derived progenitor cells (MAPCs), with extensive replication… 
2016
2016
Lab-to-clinic application of stem cell therapy for stroke
Stem cell therapy or “cell therapy” has been demonstrated to be a potent treatment intervention in animal models of acute… 
2016
2016
Abstract 177: Exploratory Results From the B01-02 Trial: Administration of MultiStem® Results in Decreased Circulating CD3+ Cells and Lower Levels of Inflammatory Cytokines
Introduction: B01-02 was a double-blind, placebo-controlled study of ischemic stroke patients (NIHSS 8-20, inclusive) treated… 
Review
2015
Review
2015
Clinical Development of MultiStem® for Treatment of Injuries and Diseases of the Central Nervous System
The translation of stem cell therapeutics, from experimental testing in preclinical animal models to clinical evaluation in human… 
2012
2012
Abstract 198: The Spleen Is A Pivotal Target Of Functional Recovery After Treatment With Multistem For Acute Ischemic Stroke
Background: There is increasing evidence to suggest that some types of stem cells enhance recovery after stroke by exerting… 
2011
2011
Company profile: Athersys.
Athersys (Nasdaq: ATHX) is a biopharmaceutical company engaged in the discovery and development of novel therapies designed to… 
2011
2011
Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial
Abstract 1987 Background. MultiStem®, a multipotent adult progenitor cells (MAPC) collection, is an immune-modulatory, bone… 
1968
1968
GENERAL THEORY OF MULTISTEM DRIFT TUBE STRUCTURES PROPOSED FOR PROTON LINACS.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)